Efficacy and safety of peginterferon alpha-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon a ribavirin: an open-label study in Central and Eastern Europe

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F11%3A%230001334" target="_blank" >RIV/65269705:_____/11:#0001334 - isvavai.cz</a>

Result on the web

<a href="http://dx.doi.org/10.1097/MEG.0b013e3283458407" target="_blank" >http://dx.doi.org/10.1097/MEG.0b013e3283458407</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1097/MEG.0b013e3283458407" target="_blank" >10.1097/MEG.0b013e3283458407</a>

Result language

angličtina

Original language name

Efficacy and safety of peginterferon alpha-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon a ribavirin: an open-label study in Central and Eastern Europe

Original language description

113 patients (56%) achieved an EVR, 107 (53%) had an end-of-treatment response and 63 patients (31%) achieved an SVR (including 38% [40/105] of those with prior breakthrough or relapse and 24% [21/88] of those with prior non-response).

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FN - Epidemiology, infection diseases and clinical immunology

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2011

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

European Journal of Gastroenterology and Hepatology

ISSN

0954-691X

e-ISSN

—

Volume of the periodical

23

Issue of the periodical within the volume

5

Country of publishing house

GB - UNITED KINGDOM

Number of pages

7

Pages from-to

375-381

UT code for WoS article

000289506800002

EID of the result in the Scopus database

—